Loading clinical trials...
Loading clinical trials...
Medication Development for Protracted Abstinence in Alcoholism: Apremilast Versus Placebo
Conditions
Interventions
Apremilast
Placebo
Locations
1
United States
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research
La Jolla, California, United States
Start Date
November 1, 2017
Primary Completion Date
April 1, 2020
Completion Date
April 1, 2020
Last Updated
September 16, 2022
NCT05855668
NCT07071779
NCT07413458
NCT06939088
NCT06793488
NCT06648642
Lead Sponsor
The Scripps Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions